Tour Anti-Doping Officials Deny Paul Seixas Favouritism Claims

What happened: Anti-doping authorities at the Tour de France have rejected accusations that Paul Seixas is receiving preferential treatment in the race’s testing programme, according to The Guardian. The dispute centres on the fact that Seixas, the 19-year-old French rider who is fourth overall, has not yet been subjected to the nocturnal test that race leader Tadej Pogacar and the now-withdrawn Jonas Vingegaard underwent.

Watch the highlights: https://www.youtube.com/watch?v=Z3yvGoT09E4

The confirmed testing detail is narrower than the controversy around it. Seixas and his Decathlon CMA CGM team were tested on Monday evening along with the rest of the peloton as part of the biological passport programme. The issue raised by rivals is not that Seixas has avoided testing altogether, but that he has not yet received the specific night-time test applied to some of the biggest names in the race.

Why it matters: At the Tour, process is part of competitive trust. A rider placed fourth overall, especially a home favourite riding a breakthrough race, will naturally draw attention from rivals, media and fans. Anti-doping programmes are judged not only by whether testing happens, but by whether the pattern of testing looks consistent and independent across nationalities, teams and standings positions.

The authorities’ denial also addresses a sensitive local angle. The Guardian reports that authorities rejected claims that the French doping agency plays a role in deciding who is tested. That distinction matters because Seixas is French, and because any perception of domestic influence would deepen suspicion even if no rule breach were established.

Tournament impact: The sporting consequence is mostly atmospheric for now. Seixas remains fourth overall based on the race standings reported by the source, while Pogacar remains the named race leader and Vingegaard is described as withdrawn. The accusations do not change the classification, but they add pressure around Seixas’ ride and around how the anti-doping operation communicates its decisions during the final phase of the Tour.

What to watch: The key follow-up is whether Seixas is later selected for the same nocturnal testing protocol, and whether officials provide more detail on how riders are chosen without compromising the programme. Rivals’ concern may fade if the testing pattern evens out, but if Seixas continues deep in contention without comparable checks, the scrutiny will likely stay attached to every strong performance.

Confidence: Confirmed by the source: Seixas is fourth overall, was tested Monday evening with Decathlon CMA CGM and the peloton, has not yet had the same nocturnal test as Pogacar and Vingegaard, and anti-doping authorities deny preferential treatment. Still unclear: the full selection criteria for night-time tests and whether Seixas will receive one later in the race.